HeartSciences Inc. has secured its first commercial SaaS revenue agreement with St. Vincent Health to deploy its MyoVista Insights platform, marking a key milestone from early adopter installations to revenue-generating deployments. MyoVista Insights is a cloud-based ECG management system that integrates AI to improve clinical workflows and is device-agnostic, designed to scale across healthcare facilities. The company expects more commercial agreements in the coming quarters as it gains market interest following its full launch at the American College of Cardiology Annual Scientific Session. This deal highlights HeartSciences' transition to mainstream commercial operations and its potential growth in healthcare technology adoption.
Analyst Dr. Kamilah Stevenson warns XRP investors that even if they are right about the asset's long-term potential, mistiming market events like adoption or regulation can lead to losses. She highlights that many key factors influencing XRP's succes...
Mayan Finance has facilitated over $20.23 billion in cross-chain swaps using Wormhole's technology, processing 9.6 million transactions from 3.4 million unique wallets. The protocol offers fast transaction times of 2 to 12 seconds and low fees, with ...
Dogecoin (DOGE) has been fully integrated onto the Solana blockchain through Wormhole's Native Token Transfers (NTT) framework and the Sunrise liquidity gateway. This integration, covering DOGE's entire $35 billion circulating supply, allows DOGE to ...
Bittensor (TAO) surged 8.33% to $264.83, nearing its $300 target after a 25% gain over five sessions. The rally is driven by new trading access on Raydium, increased activity from the parody token Buttensor, protocol upgrades, and rising derivatives ...
Bitcoin remains stuck below $80,000 following stronger-than-expected US payroll data that revived fears of a Federal Reserve rate hike. Despite a sharp drop and liquidations, market expectations for a Fed hike remain steady, with the upcoming CPI rep...
